Dr. Douglas Dieterich: “Treatment Landscape of NASH: Douglas Dieterich, MD”
Speaking in Vienna at the EASL Meeting Douglas Dieterich, MD spoke with Medpage Today. He says, “It’s wonderful that we have drugs now that are anti-fibrotics and anti-NASH drugs. Obviously the best things to do are diet and lose weight and take control of your pre-diabetes or insulin resistance. But those in the past have not been overly successful. A lot of weight loss programs and diabetes controlled programs are kind of doomed to fail. So I think if you put them all together and add the NASH drugs on top of it, it’s actually very exciting and very promising.” Learn more
Researchers Identify Potential Target for Treatment Among Patients With Type 2 Diabetes
Aug 04, 2022 View All Press Releases
Mount Sinai Researcher Receives Prestigious International Award
Jul 06, 2022 View All Press Releases
